(Q67899864)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1383131%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

0 references

1 reference

title

Cellular and humoral antigenic epitopes in HIV and SIV (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1383131%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Broliden K

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1383131%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Nixon DF

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1383131%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Ogg G

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1383131%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Broliden PA

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1383131%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

publication date

1 August 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1383131%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1383131%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1383131%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1383131%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

515-534

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1383131%20AND%20SRC:MED&resulttype=core&format=json

Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain

19 September 2019

cites work

1 reference

12 December 2020

Bispecific antibodies that mediate killing of cells infected with human immunodeficiency virus of any strain

1 reference

12 December 2020

A quantitative assay of peptide-dependent class I assembly

1 reference

12 December 2020

Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition

1 reference

12 December 2020

Biological properties of a CD4 immunoadhesin

1 reference

12 December 2020

Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody

1 reference

12 December 2020

Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein

1 reference

12 December 2020

The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?

1 reference

12 December 2020

Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution

1 reference

12 December 2020

Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity

1 reference

12 December 2020

Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro

1 reference

12 December 2020

Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine

1 reference

12 December 2020

Immunogenicity and antigenicity of conserved peptides from the envelope of HIV-1 expressed at the surface of recombinant bacteria

1 reference

12 December 2020

Immunoconjugates that neutralize HIV virions kill T cells infected with diverse strains of HIV-1.

1 reference

12 December 2020

C-terminal fragments of gp120 and synthetic peptides from five HTLV-III strains: prevalence of antibodies to the HTLV-III-MN isolate in infected individuals.

1 reference

12 December 2020

Human immunodeficiency virus neutralizing antibodies in sera from North Americans and Africans.

1 reference

12 December 2020

Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies

1 reference

12 December 2020

Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits

1 reference

12 December 2020

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

12 December 2020

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein

1 reference

12 December 2020

Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.

1 reference

12 December 2020

Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.

1 reference

12 December 2020

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

12 December 2020

A sequence pattern common to T cell epitopes

1 reference

12 December 2020

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

1 reference

12 December 2020

Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein.

1 reference

12 December 2020

Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles

1 reference

12 December 2020

T-immunogenic peptides are constituted of rare sequence patterns. Use in the identification of T epitopes in the human immunodeficiency virus gag protein

1 reference

12 December 2020

Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping

1 reference

12 December 2020

Human B-cell epitopes of HIV-2 transmembrane protein are similarly spaced as in HIV-1

1 reference

12 December 2020

Production and Characterization of a Human Monoclonal Antibody, Reactive with a Conserved Epitope on gp41 of Human Immunodeficiency Virus Type I

1 reference

12 December 2020

Demonstration of cross-reactive antibodies able to elicit lysis of both HIV-1- and HIV-2-infected cells

1 reference

12 December 2020

Primary Cytotoxicity against the Envelope Glycoprotein of Human Immunodeficiency Virus-It Evidence for Antibody-Dependent Cellular Cytotoxicity In Vivo

1 reference

12 December 2020

Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region

1 reference

12 December 2020

Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies

1 reference

12 December 2020

An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope

1 reference

12 December 2020

Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody

1 reference

12 December 2020

Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous

1 reference

12 December 2020

Glycosylation Governs the Binding of Antipeptide Antibodies to Regions of Hypervariable Amino Acid Sequence within Recombinant gp120 of Human Immunodeficiency Virus Type 1

1 reference

12 December 2020

Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells

1 reference

12 December 2020

Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus

1 reference

12 December 2020

Characterization and large production of human monoclonal antibodies against the HIV-1 envelope

1 reference

12 December 2020

Identification of a major human immunodeficiency virus-1 reverse transcriptase epitope recognized by mouse CD4+ T lymphocytes

1 reference

12 December 2020

An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag

1 reference

12 December 2020

Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast

1 reference

12 December 2020

HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells

1 reference

12 December 2020

Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes.

1 reference

12 December 2020

Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody

1 reference

12 December 2020

Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120

1 reference

12 December 2020

Peptides Mimicking Selected Disulfide Loops in HIV-1 gp120, Other Than V3, Do Not Elicit Virus-Neutralizing Antibodies

1 reference

12 December 2020

Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein

1 reference

12 December 2020

Identification of Conserved Residues in the Human Immunodeficiency Virus Type 1 Principal Neutralizing Determinant That Are Involved in Fusion

1 reference

12 December 2020

Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway

1 reference

12 December 2020

Cross-Neutralizing Antibodies in Rabbits Immunized with HIV-1 gp160 Purified from Simian Cells Infected with a Recombinant Vaccinia Virus

1 reference

12 December 2020

Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals

1 reference

12 December 2020

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide

1 reference

12 December 2020

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

12 December 2020

Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysis

1 reference

12 December 2020

A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120.

1 reference

12 December 2020

Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1.

1 reference

12 December 2020

Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution

1 reference

12 December 2020

HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1

1 reference

12 December 2020

Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide

1 reference

12 December 2020

Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein

1 reference

12 December 2020

Association of antibodies blocking HIV-1 gp 160-sCD4 attachment with virus neutralizing activity in human sera

1 reference

12 December 2020

Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding

1 reference

12 December 2020

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain

1 reference

12 December 2020

Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.

1 reference

12 December 2020

HIV-1 Neutralizing Monoclonal Antibodies Induced by a Synthetic Peptide

1 reference

12 December 2020

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

1 reference

12 December 2020

Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein

1 reference

12 December 2020

Is there a neutralization epitope in the second conserved domain of HIV-1 envelope protein?

1 reference

12 December 2020

Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys

1 reference

12 December 2020

Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies

1 reference

12 December 2020

Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins

1 reference

12 December 2020

A predominant group-specific neutralizing epitope of human immunodeficiency virus type 1 maps to residues 342 to 511 of the envelope glycoprotein gp120.

1 reference

12 December 2020

Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1

1 reference

12 December 2020

Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual

1 reference

12 December 2020

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

1 reference

12 December 2020

Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans

1 reference

12 December 2020

Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals

1 reference

12 December 2020

Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity

1 reference

12 December 2020

Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides.

1 reference

12 December 2020

A chimeric mouse-human antibody that retains specificity for HIV gp120 and mediates the lysis of HIV-infected cells

1 reference

12 December 2020

An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules

1 reference

12 December 2020

Natural immunity to HIV and its possible relationship to vaccine strategies

1 reference

12 December 2020

Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients

1 reference

12 December 2020

Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins

1 reference

12 December 2020

Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera

1 reference

12 December 2020

Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain

1 reference

12 December 2020

Identification of the residues in human CD4 critical for the binding of HIV.

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV.

1 reference

12 December 2020

Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression

1 reference

12 December 2020

Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination.

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates

1 reference

12 December 2020

T cell recognition of HIV synthetic peptides in a natural infection

1 reference

12 December 2020

A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes

1 reference

12 December 2020

The CD4 antigen: physiological ligand and HIV receptor

1 reference

12 December 2020

Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.

1 reference

12 December 2020

T cells can present antigens such as HIV gp120 targeted to their own surface molecules

1 reference

12 December 2020

Generation of human monoclonal antibodies to human immunodeficiency virus

1 reference

12 December 2020

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

1 reference

12 December 2020

Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1.

1 reference

12 December 2020

Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.

1 reference

12 December 2020

The expression of hybrid HIV:Ty virus-like particles in yeast

1 reference

12 December 2020

HIV-2 antisera cross-neutralize HIV-1.

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus

1 reference

12 December 2020

Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4.

1 reference

12 December 2020

HIV infection does not require endocytosis of its receptor, CD4.

1 reference

12 December 2020

Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120.

1 reference

12 December 2020

Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1.

1 reference

12 December 2020

Characterization of HIV-1 neutralization escape mutants

1 reference

12 December 2020

T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restriction

1 reference

12 December 2020

Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals

1 reference

12 December 2020

GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody

1 reference

12 December 2020

An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies

1 reference

12 December 2020

HIV-1 peptides induce a proliferative response in lymphocytes from infected persons.

1 reference

12 December 2020

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

12 December 2020

Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody

1 reference

12 December 2020

Cytotoxic T-cell recognition of HIV proteins and peptides

1 reference

12 December 2020

Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus

1 reference

12 December 2020

High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas

1 reference

12 December 2020

Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity

1 reference

12 December 2020

Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.

1 reference

12 December 2020

A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization

1 reference

12 December 2020

Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers

1 reference

12 December 2020

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

1 reference

12 December 2020

The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope

1 reference

12 December 2020

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

1 reference

12 December 2020

Failure of ADCC to predict HIV-associated disease progression or outcome in a haemophiliac cohort

1 reference

12 December 2020

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

1 reference

12 December 2020

T-cell antigenic sites tend to be amphipathic structures

1 reference

12 December 2020

Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo

1 reference

12 December 2020

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

1 reference

12 December 2020

Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins

1 reference

12 December 2020

Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide

1 reference

12 December 2020

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

1 reference

12 December 2020

The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens

1 reference

12 December 2020

Neutralizing monoclonal antibodies to the AIDS virus

1 reference

12 December 2020

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

1 reference

12 December 2020

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

1 reference

12 December 2020

Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120

1 reference

12 December 2020

Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans

1 reference

12 December 2020

Structure of the human class I histocompatibility antigen, HLA-A2

1 reference

12 December 2020

Lack of cross-reaction in antibody-dependent cellular cytotoxicity between human immunodeficiency virus (HIV) and HIV-related West African strains.

1 reference

12 December 2020

Induction of anti-HIV neutralizing antibodies by synthetic peptides

1 reference

12 December 2020

HIV-specific cytotoxic T lymphocytes in seropositive individuals

1 reference

12 December 2020

Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages

1 reference

12 December 2020

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

12 December 2020

Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization

1 reference

12 December 2020

Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity

1 reference

12 December 2020

Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide

1 reference

12 December 2020

Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion

1 reference

12 December 2020

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

1 reference

12 December 2020

A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2.

1 reference

12 December 2020

pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane

1 reference

12 December 2020

Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients

1 reference

12 December 2020

B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus

1 reference

12 December 2020

Biological significance of the antibody response to HIV antigens expressed on the cell surface.

1 reference

12 December 2020

Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency Virus

1 reference

12 December 2020

Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus

1 reference

12 December 2020

AIDS virus-specific cytotoxic T lymphocytes in lung disorders

1 reference

12 December 2020

Cytotoxic T-cell immunity to influenza.

1 reference

12 December 2020

Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus

1 reference

12 December 2020

Three epitopic peptides of the simian immunodeficiency virus Nef protein recognized by macaque cytolytic T lymphocytes

1 reference

12 December 2020

Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120

1 reference

12 December 2020

Identification of B-cell antigenic sites on HIV-2 gp125.

1 reference

12 December 2020

Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation

1 reference

12 December 2020

A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research

1 reference

12 December 2020

Biological properties of anti-CD4 autoantibodies purified from HIV-infected patients

1 reference

12 December 2020

An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.

1 reference

12 December 2020

Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization

1 reference

12 December 2020

Approaches and issues in the development of vaccines against HIV.

1 reference

12 December 2020

Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route

1 reference

12 December 2020

Antibodies against defined carbohydrate structures of Candida albicans protect H9 cells against infection with human immunodeficiency virus-1 in vitro

1 reference

12 December 2020

Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans

1 reference

12 December 2020

High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals

1 reference

12 December 2020

Production and characterization of human monoclonal antibodies against core protein p25 and transmembrane glycoprotein gp41 of HIV-1.

1 reference

12 December 2020

Long-term T-cell-mediated immunity to epstein-barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes

1 reference

12 December 2020

Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis

1 reference

12 December 2020

Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins

1 reference

12 December 2020

Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes

1 reference

12 December 2020

Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection

1 reference

12 December 2020

Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain

1 reference

12 December 2020

Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene.

1 reference

12 December 2020

Immunodominance and antigenic variation of the principal neutralization domain of HIV-1.

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1383131%20AND%20SRC:MED&resulttype=core&format=json